TrialMolecular therapy : the journal of the American Society of Gene Therapy2015

Treatment of CD33-directed chimeric antigen receptor-modified T cells in one patient with relapsed and refractory acute myeloid leukemia.

Quan-shun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.